MedTrace Logo

Screening Women at High Genetic Risk for Ovarian Cancer

NCT00033488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for ovarian cancer.

PURPOSE: Screening trial to determine the best procedure to detect ovarian cancer in women who have a high genetic risk for developing ovarian cancer.

Conditions

Interventions

OTHER

cytology specimen collection procedure

PROCEDURE

annual screening

PROCEDURE

comparison of screening methods

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • James Mackay, MD, MA, FRCP, FRCPE · Institute of Child Health

Study Design

Purpose
SCREENING

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Completion
2010-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00033488 on ClinicalTrials.gov